Kenneth C Cundy Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Kenneth C Cundy.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Kenneth C Cundy. Kenneth C Cundy is SVP, Preclinical Development in XENOPORT INC ($XNPT) and Chief Scientific Officer in CohBar, Inc. ($COB.U:TSXV).

Latest Insider Trading Transactions of Kenneth C Cundy

Sentiment: All, COBU, XNPT

Page:   < prev 1 2 3 4 5 6 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 05 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS61.591006,15919,77519.9 K to 19.8 K (-0.50 %)
Feb 05 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS61.541006,15419,87520 K to 19.9 K (-0.50 %)
Feb 05 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS61.751006,17519,97520.1 K to 20 K (-0.50 %)
Feb 05 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS61.601006,16020,07520.2 K to 20.1 K (-0.50 %)
Feb 05 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS63.561063620,17520.2 K to 20.2 K (-0.05 %)
Feb 05 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS63.62905,72620,18520.3 K to 20.2 K (-0.44 %)
Feb 01 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA0.002,50002,500
Feb 01 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...Option ExerciseA59.1718,0001,065,06018,000
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.341005,53420,27520.4 K to 20.3 K (-0.49 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.711005,57120,37520.5 K to 20.4 K (-0.49 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.941005,59420,47520.6 K to 20.5 K (-0.49 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.781005,57820,57520.7 K to 20.6 K (-0.48 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.321005,63220,67520.8 K to 20.7 K (-0.48 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.531005,65320,77520.9 K to 20.8 K (-0.48 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.001005,60020,87521 K to 20.9 K (-0.48 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.151005,61520,97521.1 K to 21 K (-0.47 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.031005,60321,07521.2 K to 21.1 K (-0.47 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.761005,67621,17521.3 K to 21.2 K (-0.47 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.341005,53421,27521.4 K to 21.3 K (-0.47 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.711005,57121,37521.5 K to 21.4 K (-0.47 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.951005,59521,47521.6 K to 21.5 K (-0.46 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.841005,58421,57521.7 K to 21.6 K (-0.46 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.021005,60221,67521.8 K to 21.7 K (-0.46 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.73281,56021,77521.8 K to 21.8 K (-0.13 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.74724,01321,80321.9 K to 21.8 K (-0.33 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.251005,62521,87522 K to 21.9 K (-0.46 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.911005,59121,97522.1 K to 22 K (-0.45 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.501005,65022,07522.2 K to 22.1 K (-0.45 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.721005,67222,17522.3 K to 22.2 K (-0.45 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.701005,57022,27522.4 K to 22.3 K (-0.45 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.131005,61322,37522.5 K to 22.4 K (-0.44 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.241005,62422,47522.6 K to 22.5 K (-0.44 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.271005,52722,57522.7 K to 22.6 K (-0.44 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.951005,59522,67522.8 K to 22.7 K (-0.44 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.931005,59322,77522.9 K to 22.8 K (-0.44 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.741005,57422,87523 K to 22.9 K (-0.44 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.941005,59422,97523.1 K to 23 K (-0.43 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.501005,65023,07523.2 K to 23.1 K (-0.43 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.721005,67223,17523.3 K to 23.2 K (-0.43 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.281005,52823,27523.4 K to 23.3 K (-0.43 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.711005,57123,37523.5 K to 23.4 K (-0.43 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.941005,59423,47523.6 K to 23.5 K (-0.42 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS55.771005,57723,57523.7 K to 23.6 K (-0.42 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.311005,63123,67523.8 K to 23.7 K (-0.42 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.531005,65323,77523.9 K to 23.8 K (-0.42 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.001005,60023,87524 K to 23.9 K (-0.42 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.151005,61523,97524.1 K to 24 K (-0.42 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.021005,60224,07524.2 K to 24.1 K (-0.41 %)
Jan 04 2008XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS56.721005,67224,17524.3 K to 24.2 K (-0.41 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.151005,41524,27524.4 K to 24.3 K (-0.41 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.901005,39024,37524.5 K to 24.4 K (-0.41 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.001005,40024,47524.6 K to 24.5 K (-0.41 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.301005,43024,57524.7 K to 24.6 K (-0.41 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.011005,40124,67524.8 K to 24.7 K (-0.40 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.001005,40024,77524.9 K to 24.8 K (-0.40 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.731005,37324,87525 K to 24.9 K (-0.40 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.471005,34724,97525.1 K to 25 K (-0.40 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.311005,33125,07525.2 K to 25.1 K (-0.40 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.201005,32025,17525.3 K to 25.2 K (-0.40 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.401005,34025,27525.4 K to 25.3 K (-0.39 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.101005,31025,37525.5 K to 25.4 K (-0.39 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.821005,28225,47525.6 K to 25.5 K (-0.39 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.751005,27525,57525.7 K to 25.6 K (-0.39 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.861005,28625,67525.8 K to 25.7 K (-0.39 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.781005,27825,77525.9 K to 25.8 K (-0.39 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.601005,26025,87526 K to 25.9 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.091005,20925,97526.1 K to 26 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS51.621005,16226,07526.2 K to 26.1 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS51.611005,16126,17526.3 K to 26.2 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.001005,40026,27526.4 K to 26.3 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.311005,43126,37526.5 K to 26.4 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.901005,39026,47526.6 K to 26.5 K (-0.38 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.721005,37226,57526.7 K to 26.6 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.311005,33126,67526.8 K to 26.7 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.401005,34026,77526.9 K to 26.8 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.821005,28226,87527 K to 26.9 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.871005,28726,97527.1 K to 27 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.601005,26027,07527.2 K to 27.1 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS51.621005,16227,17527.3 K to 27.2 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.011005,40127,27527.4 K to 27.3 K (-0.37 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS54.311005,43127,37527.5 K to 27.4 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.901005,39027,47527.6 K to 27.5 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.691005,36927,57527.7 K to 27.6 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.251005,32527,67527.8 K to 27.7 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS53.401005,34027,77527.9 K to 27.8 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.821005,28227,87528 K to 27.9 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.861005,28627,97528.1 K to 28 K (-0.36 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS52.601005,26028,07528.2 K to 28.1 K (-0.35 %)
Dec 04 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS51.611005,16128,17528.3 K to 28.2 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.341004,93428,27528.4 K to 28.3 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.301004,93028,37528.5 K to 28.4 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.901004,89028,47528.6 K to 28.5 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.731004,97328,57528.7 K to 28.6 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.011004,80128,67528.8 K to 28.7 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.701004,97028,77528.9 K to 28.8 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.871004,88728,87529 K to 28.9 K (-0.35 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.231004,82328,97529.1 K to 29 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.691004,96929,07529.2 K to 29.1 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.331004,93329,17529.3 K to 29.2 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.831258629,27529.3 K to 29.3 K (-0.04 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.711004,97129,28729.4 K to 29.3 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.711004,97129,38729.5 K to 29.4 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.041004,90429,48729.6 K to 29.5 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.331004,93329,58729.7 K to 29.6 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.901004,99029,68729.8 K to 29.7 K (-0.34 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.361004,93629,78729.9 K to 29.8 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.721004,97229,88730 K to 29.9 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.681004,96829,98730.1 K to 30 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.571004,95730,08730.2 K to 30.1 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.901004,99030,18730.3 K to 30.2 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.751004,97530,28730.4 K to 30.3 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.581004,95830,38730.5 K to 30.4 K (-0.33 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.592009,91830,48730.7 K to 30.5 K (-0.65 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.602009,92030,68730.9 K to 30.7 K (-0.65 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.751004,97530,88731 K to 30.9 K (-0.32 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.301004,93030,98731.1 K to 31 K (-0.32 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.301004,93031,08731.2 K to 31.1 K (-0.32 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.731004,97331,18731.3 K to 31.2 K (-0.32 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.901004,99031,28731.4 K to 31.3 K (-0.32 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.231004,82331,38731.5 K to 31.4 K (-0.32 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.83934,54131,48731.6 K to 31.5 K (-0.29 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.722009,94431,58031.8 K to 31.6 K (-0.63 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.85884,29931,78031.9 K to 31.8 K (-0.28 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.84734231,86831.9 K to 31.9 K (-0.02 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.761004,97631,87532 K to 31.9 K (-0.31 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.231004,82331,97532.1 K to 32 K (-0.31 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.50281,38632,07532.1 K to 32.1 K (-0.09 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.52723,56532,10332.2 K to 32.1 K (-0.22 %)
Nov 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.601004,96032,17532.3 K to 32.2 K (-0.31 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.911004,89132,27532.4 K to 32.3 K (-0.31 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.671004,86732,37532.5 K to 32.4 K (-0.31 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.641004,96432,47532.6 K to 32.5 K (-0.31 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.621004,96232,57532.7 K to 32.6 K (-0.31 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS50.021785032,67532.7 K to 32.7 K (-0.05 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS50.04834,15332,69232.8 K to 32.7 K (-0.25 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.721004,97232,77532.9 K to 32.8 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.311004,93132,87533 K to 32.9 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.171004,91732,97533.1 K to 33 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.991004,89933,07533.2 K to 33.1 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.471004,84733,17533.3 K to 33.2 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.691004,96933,27533.4 K to 33.3 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.661004,86633,37533.5 K to 33.4 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.641004,96433,47533.6 K to 33.5 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.601004,96033,57533.7 K to 33.6 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS50.001005,00033,67533.8 K to 33.7 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.311004,93133,77533.9 K to 33.8 K (-0.30 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS49.171004,91733,87534 K to 33.9 K (-0.29 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.961004,89633,97534.1 K to 34 K (-0.29 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.911004,89134,07534.2 K to 34.1 K (-0.29 %)
Oct 02 2007XNPTXENOPORT INCCundy Kenneth CSVP, Preclinical De ...SellS48.481004,84834,17534.3 K to 34.2 K (-0.29 %)

Page:   < prev 1 2 3 4 5 6 next >